Related Experiment Videos
Akt inhibits DNA damage by suppressing p73, p53, Forkhead or all three?
1Signol Transduclion Laboratory, Cancer Reseorch UK, London Research Institute, 44 Lincoln's Inn Fields, London, WC2A 3PX United Kingdom. s.basu@concer.org.uk
Cell Cycle (Georgetown, Tex.)
|April 16, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Enhanced ELL Phase Separation Is Crucial for Efficient DNA Damage Repair to Restart Transcription and Cell Survival.
Molecular and cellular biology·2025
Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI).
Journal for immunotherapy of cancer·2025
Spatial interaction mapping of PD-1/PD-L1 in head and neck cancer reveals the role of macrophage-tumour barriers associated with immunotherapy response.
Journal of translational medicine·2025
Negative Feedback Loop Mechanism between EAF1/2 and DBC1 in Regulating ELL Stability and Functions.
Molecular and cellular biology·2022
Human FKBP5 Negatively Regulates Transcription through Inhibition of P-TEFb Complex Formation.
Molecular and cellular biology·2021
Upregulation of ITM2A by p53 activation modulates p53 function through physical interaction.
Cell cycle (Georgetown, Tex.)·2026
The hormetic landscape: from evolutionary origination to mechanistic pathways in therapeutics.
Cell cycle (Georgetown, Tex.)·2026
The effect of energy metabolism on embryonic development and endometrial receptivity in patients with repeated implantation failure.
Cell cycle (Georgetown, Tex.)·2026
The role of IL-37 in inflammatory bowel disease and colitis-associated colorectal cancer.
Cell cycle (Georgetown, Tex.)·2026
Exploratory multi-omics links CCL2/TIMP1 axis to immunosuppressive TME in glioblastoma.
Cell cycle (Georgetown, Tex.)·2026
A marine-derived meroterpenoid inhibits colorectal cancer via PI3K pathway modulation in mice.
Marine life science & technology·2026
SGLT2 inhibitor therapy is associated with IL-10/TGF-α/sVEGFR3 signalling and adipose tissue remodelling in advanced heart failure.
Journal of molecular and cellular cardiology plus·2026